Indegene Ltd (INDGN) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.071x

Based on the latest financial reports, Indegene Ltd (INDGN) has a cash flow conversion efficiency ratio of 0.071x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.03 Billion ≈ $21.93 Million USD) by net assets (Rs28.66 Billion ≈ $309.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See INDGN equity financing ratio to measure how much of total assets are equity-financed.

Indegene Ltd - Cash Flow Conversion Efficiency Trend (2020–2026)

This chart illustrates how Indegene Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check INDGN cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Indegene Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Indegene Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Guangdong Xianglu Tungsten Co Ltd
SHE:002842
-0.016x
J & J Snack Foods Corp
NASDAQ:JJSF
0.018x
Harrow Health Inc
NASDAQ:HROW
-0.317x
HIAG Immobilien Holding AG
SW:HIAG
0.015x
Babcock & Wilcox Enterprises Inc
NYSE:BW
-0.103x
Arcelik AS
IS:ARCLK
-0.210x
Qisda Corp
TW:2352
-0.072x
Grupo Nacional Provincial S.A.B
MX:GNP
-0.024x

Annual Cash Flow Conversion Efficiency for Indegene Ltd (2020–2026)

The table below shows the annual cash flow conversion efficiency of Indegene Ltd from 2020 to 2026. For the full company profile with market capitalisation and key ratios, see INDGN market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs31.39 Billion
≈ $339.44 Million
Rs6.63 Billion
≈ $71.74 Million
0.211x +25.10%
2025-03-31 Rs26.16 Billion
≈ $282.87 Million
Rs4.42 Billion
≈ $47.79 Million
0.169x -52.44%
2024-03-31 Rs14.29 Billion
≈ $154.55 Million
Rs5.08 Billion
≈ $54.91 Million
0.355x +190.20%
2023-03-31 Rs10.64 Billion
≈ $115.04 Million
Rs1.30 Billion
≈ $14.08 Million
0.122x -68.52%
2022-03-31 Rs7.64 Billion
≈ $82.61 Million
Rs2.97 Billion
≈ $32.12 Million
0.389x -24.71%
2021-03-31 Rs3.33 Billion
≈ $36.02 Million
Rs1.72 Billion
≈ $18.60 Million
0.516x +136.17%
2020-03-31 Rs-155.98 Million
≈ $-1.69 Million
Rs222.73 Million
≈ $2.41 Million
-1.428x --

About Indegene Ltd

NSE:INDGN India Health Information Services
Market Cap
$1.42 Billion
Rs131.03 Billion INR
Market Cap Rank
#7353 Global
#365 in India
Share Price
Rs545.25
Change (1 day)
+5.84%
52-Week Range
Rs423.50 - Rs589.55
All Time High
Rs732.70
About

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It al… Read more